AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms
A Parkinson's disease that has material basis in mutation in the FBXO7 gene on chromosome 22q12.3.
A Parkinson's disease that has material basis in mutation in the FBXO7 gene on chromosome 22q12.3.
From the Open Targets disease record ↗
🧠 Brain and nerves: In neurodegenerative diseases, nerve cells in the brain or spinal cord stop working and die over time - affecting memory (Alzheimer's disease), movement (Parkinson's disease) or muscles (ALS).
General information about brain and nerves, reviewed by people; it does not describe any one person. Below: the evidence for parkinsonian-pyramidal syndrome itself.
AI reads the targets, drugs, trials and papers below and writes where the science stands — every claim cited. It is shared with everyone who opens parkinsonian-pyramidal syndrome.
Green labels: what the target is known to be druggable by. The score combines genetics, somatic mutations, drugs, expression and literature.
No drugs recorded yet.
AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy
HealthTeky